RBC Europe’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-388
Closed -$3.78K 1182
2018
Q2
$3.78K Buy
+388
New +$3.78K ﹤0.01% 1004